Meta Pixel

News and Announcements

Van Leeuwenhoeck Institute initiates Research Coverage with OncoSil

  • Published October 02, 2015 4:41PM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

1st October 2015, ASX Announcement

OncoSil Medical Limited (OncoSil Medical, the Company) is pleased to announce that international life sciences research group, Van Leeuwenhoeck Institute, has initiated analyst research coverage on the Company.

The Van Leeuwenhoeck Institute research report is available via the OncoSil Medical company website;

www.oncosil.com.au

OncoSil Medical is focused on the commercialisation of its lead product candidate, the OncoSil localised radiation treatment for cancer. It is concurrently seeking a Conformité Européenne (CE) Mark for OncoSil for pancreatic and primary liver cancer (HCC), which would facilitate commercialisation in the European Union and other major markets (including Australia, Canada and Singapore), and US approval via the US FDA.

To read the full announcement, please click here.

Capital Insights
Where’s the beef? Blackstone just answered the AI question.

In 1984, a fast food ad asked a question that became a catchphrase. Where’s the beef? Jon Gray, President of Blackstone, used that line this month in front of global LPs. It is the question every capital allocator is asking about AI. Trillions of dollars are going into chips, data centres and power. That is […]

Company Updates
The Best of Both Worlds: How Omnique Fund is Rewiring Real World Assets via Tokenisation

For decades, the playbook for Australia’s wholesale investors has remained relatively unchanged: pick between the slow-moving, illiquid reliability of tangible assets like property and gold, or chase the frictionless, high-velocity liquidity of public equity and digital markets. But as macroeconomic volatility spikes and a structural housing deficit reshapes private debt demand, sophisticated investors are demanding […]

Join over 45,000+ sophisticated investors

Join Now